Jon P. Stonehouse
2017
In 2017, Jon P. Stonehouse earned a total compensation of $3.9M as President, Chief Executive Officer and Director at BioCryst Pharmaceuticals, a 209% increase compared to previous year.
Compensation breakdown
Bonus | $243,019 |
---|---|
Non-Equity Incentive Plan | $220,862 |
Option Awards | $2,910,080 |
Salary | $532,823 |
Other | $14,405 |
Total | $3,921,189 |
Stonehouse received $2.9M in option awards, accounting for 74% of the total pay in 2017.
Stonehouse also received $243K in bonus, $220.9K in non-equity incentive plan, $532.8K in salary and $14.4K in other compensation.
Rankings
In 2017, Jon P. Stonehouse's compensation ranked 2,621st out of 14,666 executives tracked by ExecPay. In other words, Stonehouse earned more than 82.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,621 | 82nd |
Manufacturing | 907 | 84th |
Chemicals And Allied Products | 240 | 88th |
Drugs | 184 | 89th |
Biological Products, Except Diagnostic Substances | 34 | 89th |
Stonehouse's colleagues
We found four more compensation records of executives who worked with Jon P. Stonehouse at BioCryst Pharmaceuticals in 2017.
2017
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2017
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
2017
Yarlagadda Babu
BioCryst Pharmaceuticals
Senior Vice President of Drug Discovery
2017
Lynne Powell
BioCryst Pharmaceuticals